rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-4-8
|
pubmed:abstractText |
To determine if obese non-insulin-dependent diabetic patients lose more weight when treated for 24 weeks (6 months) with orlistat (120 mg t.i.d.), in conjunction with a hypocaloric diet plus behavioural counselling, than when treated by placebo (t.i.d.) plus similar instructions. The secondary objectives were to evaluate the effects on glucose profile and to determine the tolerability and safety of orlistat.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1462-8902
|
pubmed:author |
pubmed-author:AschnerPP,
pubmed-author:BarrancoJJ,
pubmed-author:GrossJJ,
pubmed-author:HalpernAA,
pubmed-author:JadzinskyMM,
pubmed-author:ManciniM CMC,
pubmed-author:MatosA GAG,
pubmed-author:RamirezLL,
pubmed-author:RepettoGG,
pubmed-author:SuplicyHH,
pubmed-author:ZanellaM TMT
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
180-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12681025-Adolescent,
pubmed-meshheading:12681025-Adult,
pubmed-meshheading:12681025-Aged,
pubmed-meshheading:12681025-Anthropometry,
pubmed-meshheading:12681025-Anti-Obesity Agents,
pubmed-meshheading:12681025-Blood Glucose,
pubmed-meshheading:12681025-Blood Pressure,
pubmed-meshheading:12681025-Combined Modality Therapy,
pubmed-meshheading:12681025-Diabetes Mellitus,
pubmed-meshheading:12681025-Diabetes Mellitus, Type 2,
pubmed-meshheading:12681025-Diet, Reducing,
pubmed-meshheading:12681025-Double-Blind Method,
pubmed-meshheading:12681025-Enzyme Inhibitors,
pubmed-meshheading:12681025-Female,
pubmed-meshheading:12681025-Hemoglobin A, Glycosylated,
pubmed-meshheading:12681025-Humans,
pubmed-meshheading:12681025-Insulin,
pubmed-meshheading:12681025-Lactones,
pubmed-meshheading:12681025-Lipase,
pubmed-meshheading:12681025-Lipids,
pubmed-meshheading:12681025-Male,
pubmed-meshheading:12681025-Middle Aged,
pubmed-meshheading:12681025-Obesity,
pubmed-meshheading:12681025-Risk Factors,
pubmed-meshheading:12681025-Weight Loss
|
pubmed:year |
2003
|
pubmed:articleTitle |
Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.
|
pubmed:affiliation |
Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brazil. halpern@netpoint.com.br
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|